• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ASHP 治疗立场声明:确定和预防肺炎球菌耐药性的策略。

ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.

机构信息

Kimberly A. Couch, Pharm.D., M.A., FIDSA, FASHP, is President, Infectious Diseases Pharmacy Associates, Stevensville, MD, and Clinical Pharmacist, Complete Rx, Seaford, DE. Teresa Geide, Pharm. D., BCPS, CGP, is Clinical Pharmacy Specialist, Infectious Diseases, Orlando Veterans Affairs Medical Center, Orlando, FL.

出版信息

Am J Health Syst Pharm. 2014 Mar 1;71(5):417-24. doi: 10.2146/ajhp130514.

DOI:10.2146/ajhp130514
PMID:24534597
Abstract

The incidence of MDRSP continues to increase, causing significant morbidity and mortality. Health care providers should seize the opportunity to promote the judicious use of antimicrobials and vaccinate patients with the pneumococcal vaccines as a means to lessen this significant health problem. Pharmacists are poised to play a key role in patient care by assessing for the need and administering vaccines in compliance with the current guidelines. A pharmacist should have a key role on the antimicrobial stewardship team.

摘要

耐甲氧西林金黄色葡萄球菌(MDRSP)的发病率持续上升,导致发病率和死亡率显著升高。医疗保健提供者应抓住机会,促进抗菌药物的合理使用,并为患者接种肺炎球菌疫苗,以减轻这一重大健康问题。药剂师通过评估需求并按照当前指南管理疫苗,有望在患者护理中发挥关键作用。药剂师应在抗菌药物管理团队中发挥关键作用。

相似文献

1
ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.ASHP 治疗立场声明:确定和预防肺炎球菌耐药性的策略。
Am J Health Syst Pharm. 2014 Mar 1;71(5):417-24. doi: 10.2146/ajhp130514.
2
ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.美国卫生系统药师协会关于识别和预防肺炎球菌耐药策略的治疗立场声明。
Am J Health Syst Pharm. 2004 Nov 15;61(22):2430-5. doi: 10.1093/ajhp/61.22.2430.
3
Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.耐抗生素肺炎球菌的变化趋势:并非全是坏消息。
Clin Infect Dis. 2005 Aug 15;41 Suppl 4:S228-33. doi: 10.1086/430782.
4
Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.2001-2008 年希腊克里特岛成人肺炎链球菌临床分离株的血清型分布和抗菌药物耐药性。
Chemotherapy. 2010;56(4):325-32. doi: 10.1159/000320152. Epub 2010 Aug 17.
5
Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.2011 年至 2016 年中国 17 个城市肺炎链球菌分离株的血清型分布和抗生素耐药性。
BMC Infect Dis. 2017 Dec 29;17(1):804. doi: 10.1186/s12879-017-2880-0.
6
[Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].[免疫接种与抗菌药物。针对肺炎链球菌的作用之间是否存在关联?]
Rev Esp Quimioter. 2007 Mar;20(1):125-7.
7
Antimicrobial-resistant Streptococcus pneumoniae: trends and management.耐抗菌药物肺炎链球菌:趋势与管理
Expert Rev Anti Infect Ther. 2008 Oct;6(5):619-35. doi: 10.1586/14787210.6.5.619.
8
Pneumococcal resistance in the postvaccine era.
Pediatr Infect Dis J. 2006 Apr;25(4):382-3. doi: 10.1097/01.inf.0000210460.21966.f1.
9
[An update of Streptococcus pneumoniae: from genomic to clinic].[肺炎链球菌的最新进展:从基因组到临床]
Med Mal Infect. 2010 Oct;40(10):605-9. doi: 10.1016/j.medmal.2010.07.014. Epub 2010 Oct 8.
10
ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.美国卫生系统药师协会关于肺炎球菌耐药性识别与预防策略的治疗立场声明。
Am J Health Syst Pharm. 1997 Mar 1;54(5):575-8. doi: 10.1093/ajhp/54.5.575.

引用本文的文献

1
Does information by pharmacists convince the public to get vaccinated for pneumococcal disease and herpes zoster?药剂师提供的信息能否说服公众接种肺炎球菌病和带状疱疹疫苗?
Ir J Med Sci. 2022 Oct;191(5):2193-2200. doi: 10.1007/s11845-021-02778-x. Epub 2021 Oct 28.